| Literature DB >> 35479562 |
Wei Li1, Lin Zhao1, Li-Tong Sun1, Ze-Ping Xie2, Shu-Min Zhang2, Xi-Dian Yue3, Sheng-Jun Dai1.
Abstract
Two unique trinorlabdane diterpenoid alkaloids, forsyqinlingines A (1) and B (2), were isolated from the ripe fruits of Forsythia suspensa. Their structures, including absolute stereochemical configurations, were fully elucidated from extensive spectroscopy experiments, single-crystal X-ray diffraction, and electronic circular dichroism (ECD). In addition, a plausible biosynthetic pathway for the formation of compounds 1 and 2 in Forsythia suspensa was also proposed. In vitro, the two C17-labdane diterpenoid alkaloids exhibited anti-inflammatory activities by inhibiting the release of β-glucuronidase in rat polymorphonuclear leukocytes (PMNs), and antiviral activities against influenza A (H1N1) virus and respiratory syncytial virus (RSV). This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35479562 PMCID: PMC9040924 DOI: 10.1039/d1ra05760j
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Chemical structures of compounds 1 and 2.
Fig. 2The key 1H–1H COSY () and HMBC () correlations of compounds 1 and 2.
NMR data for compounds 1 and 2 (400 MHz for 1H, and 100 MHz for 13C)a,b
| No. | 1 (DMSO- | 2 (DMSO- | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1 | 1.70 (m, H-1a) | 36.6 | 1.76 (m, H-1a) | 36.8 |
| 2.21 (m, H-1b) | 2.52 (m, H-1b) | |||
| 2 | 1.28 (m, H-2a) | 28.2 | 2.43 (m, H-2a) | 34.6 |
| 1.62 (m, H-2b) | 2.67 (m, H-2b) | |||
| 3 | 3.08 (br t, 7.2) | 77.0 | 216.1 | |
| 4 | 39.1 | 47.1 | ||
| 5 | 1.18 (dd, 2.2, 12.4) | 49.7 | 1.86 (dd, 2.0, 12.4) | 49.7 |
| 6 | 1.84 (m, H-6a) | 18.8 | 1.72 (m, H-6a) | 19.8 |
| 1.87 (m, H-6b) | 1.82 (m, H-6b) | |||
| 7 | 2.77 (m, H-7a) | 33.7 | 2.81 (m, H-7a) | 33.5 |
| 2.89 (dd, 5.6, 18.2, H-7b) | 2.93 (dd, 5.6, 18.0, H-7b) | |||
| 8 | 154.6 | 154.1 | ||
| 9 | 141.5 | 140.0 | ||
| 10 | 37.1 | 36.6 | ||
| 11 | 7.48 (d, 8.1) | 133.2 | 7.62 (d, 8.2) | 147.0 |
| 12 | 6.94 (d, 8.1) | 121.0 | 7.03 (d, 8.2) | 121.5 |
| 13 | 154.6 | 154.9 | ||
| 16 | 2.33 (s, 3H) | 24.0 | 2.37 (s, 3H) | 23.7 |
| 18 | 0.98 (s, 3H) | 28.7 | 1.08 (s, 3H) | 26.8 |
| 19 | 0.77 (s, 3H) | 16.3 | 1.03 (s, 3H) | 21.3 |
| 20 | 1.07 (s, 3H) | 25.1 | 1.19 (s, 3H) | 24.4 |
| 3-OH | 4.45 (br s) | |||
Chemical shift values were in ppm and J values (in Hz) were presented in parentheses.
The assignments were based on HMQC, HMBC, and 1H–1H COSY experiments.
Fig. 3The key NOESY () correlations of compounds 1 and 2.
Fig. 4X-ray crystal structure of compound 1.
Fig. 5ECD spectrum of compound 2.
Scheme 1Proposed biogenetic pathway of compounds 1 and 2.
Inhibitory activities of compounds 1 and 2 to the release of β-glucuronidasea
| Compounds | Inhibition rate (%) |
|---|---|
| Ginkgolide B | 54.1 ± 2.35 |
| 1 | 56.7 ± 2.42 |
| 2 | 58.6 ± 3.01 |
The inhibitory rates of two novel trinorlabdane diterpenoid alkaloids (1 and 2) and ginkgolide B were tested at a concentration of 10 μM.
Positive control substance.
Anti-viral activities of compounds 1 and 2 against influenza A (H1N1) virus and respiratory syncytial virus (RSV)
| Compounds | IC50 (μM, against H1N1) | EC50 (μM, against RSV) |
|---|---|---|
| 1 | 6.9 | 5.0 |
| 2 | 7.7 | 4.8 |
Fig. 6Cell viability of different concentrations of compounds 1 and 2 on MDCK cells.